Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 8 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
Rafal Dworakowski
Research Area(s) / Expertise:

Expertise

Intervention
Job title: Medical Affairs Director for Asia-Pacific (Structural Heart)
Prof Rafał Dworakowski, MD (Hons), PhD, FRCP, FESC is an interventional cardiologist and academic with over two decades of experience in structural and coronary interventions. He has performed a high volume of TAVI procedures using various platforms via transfemoral and alternative access routes. He is also experienced in echocardiography and cardiac CT imaging.Prof Dworakowski has extensive… View more
TAVR for Aortic Insufficiency
Author(s): Marwan Amara , Yair Feld Added: 1 month ago

Cardiovascular Surgery

Intervention
Minimalist TAVI Anaesthesia Noninferior to Standard Care
Added: 2 months ago Source:  Radcliffe Cardiology
Minimalist treatment strategies for transcatheter aortic valve implantation (TAVI) are becoming more common, but have been supported by limited data from large randomised trials.² The DOUBLE-CHOICE trial was designed to evaluate the safety and efficacy of a minimalist approach (MA) using isolated local anaesthesia compared with the standard of care (SoC) with conscious sedation for transfemoral… View more

Demographic

Guidelines & Statements
EuroPCR 25: LANDMARK 1Y Outcomes
Author(s): Patrick W Serruys Added: 8 months ago
EuroPCR 25 - Novel Myval THV shows non-inferiority at one year compared to established valves in severe aortic stenosis.We are joined by Dr Patrick Serruys (Erasmus University Medical Center, Rotterdam, NL) to discuss key findings from the LANDMARK trial.This multinational, multicentric, randomized controlled trial compared the safety and effectiveness of the Myval THV Series against contemporary… View more

Intervention

Vascular Disease and Surgery
Research Area(s) / Expertise:

Expertise

Intervention
Job title: Specialist in cardiac surgery
Specialist in cardiac surgery since 2014, Dr Maurizio Taramasso has completed his surgical training at the San Raffaele University Hospital in Milan, Italy. He has also done specific cross-training in interventional cardiology and heart valve transcatheter therapies (mitral and aortic) at the San Raffaele University Hospital. His main areas of interest include surgical and catheter treatments of… View more
Transcatheter Heart Valves with Labelling for Aortic Regurgitation
Author(s): Pier Pasquale Leone , Azeem Latib Added: 4 months ago

Intervention

Vascular Disease and Surgery
Novel Technique Retrieving a Fractured Guiding Catheter
Author(s): Jia Min Chua , Paul Jau Lueng Ong , Randal Jun Bang Low Added: 6 months ago

Intervention

MI/ACS
TAVR vs Surgery: PARTNER 3 7-Year Low-Risk Outcomes
Added: 3 months ago Source:  Radcliffe Cardiology
Long-term data from the PARTNER 3 trial show no significant differences in key clinical outcomes at 7 years between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This extended follow-up provides crucial insights into the durability and long-term safety of both procedures in this patient… View more

Guidelines & Statements

Heart Failure
BCIS TAVI Position Statement
Author(s): David Hildick-Smith , Daniel J Blackman , Jonathan Byrne , et al Added: 2 weeks ago

Guidelines & Statements

Intervention